The space for AI-driven drug development is heating up, and the CNRD is jumping in with a focus on new therapeutic antibodies. It will collaborate with Schrödinger, a startup in...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)